Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
35.25
0.00 (0.00%)
At close: Dec 3, 2025
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,806 employees as of December 31, 2024. The number of employees increased by 66 or 3.79% compared to the previous year.
Employees
1,806
Change (1Y)
66
Growth (1Y)
3.79%
Revenue / Employee
$1,563,920
Profits / Employee
$730
Market Cap
12.54B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Swedish Orphan Biovitrum AB News
- 22 days ago - Positioning Barbados as the Caribbean's Life Sciences Hub - Benzinga
- 6 weeks ago - Data presented at ACR Convergence 2025 highlight Sobi's commitment to advancing care across rare and underserved inflammatory conditions - Benzinga
- 6 weeks ago - Swedish Orphan Biovitrum AB (BIOVF) Q3 2025 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 6 weeks ago - Q3 2025 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript - GuruFocus
- 6 weeks ago - Swedish Orphan Biovitrum AB (publ) (SWOBY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Swedish Orphan Biovitrum AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Sobi Q3 Adj. EBITA Rises - Nasdaq
- 6 weeks ago - Sobi raises 2025 financial forecast after Q3 revenue jumps 21% - Seeking Alpha